| Title |
Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy
|
|---|---|
| Published in |
Drug Design, Development and Therapy, January 2021
|
| DOI | 10.2147/dddt.s285852 |
| Pubmed ID | |
| Authors |
Magdalena Rudzińska, Cenk Daglioglu, Lyudmila V Savvateeva, Fatma Necmiye Kaci, Rodolphe Antoine, Andrey A Zamyatnin |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 83 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 11% |
| Student > Ph. D. Student | 9 | 11% |
| Student > Bachelor | 7 | 8% |
| Researcher | 6 | 7% |
| Professor > Associate Professor | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 43 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 15 | 18% |
| Chemistry | 4 | 5% |
| Immunology and Microbiology | 4 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Medicine and Dentistry | 3 | 4% |
| Other | 7 | 8% |
| Unknown | 47 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2021.
All research outputs
#16,059,145
of 25,387,668 outputs
Outputs from Drug Design, Development and Therapy
#927
of 2,269 outputs
Outputs of similar age
#289,922
of 519,506 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 41 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,506 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.